Reactive oxygen species production is involved in quercetin-induced apoptosis in human hepatoma cells

被引:41
作者
Chang, Yuh-Fang
Chi, Chin-Wen
Wang, Jane-Jen
机构
[1] Natl Taipei Coll Nursing, Taipei 11219, Taiwan
[2] Vet Gen Hosp, Dept Med Res, Taipei 11217, Taiwan
[3] Vet Gen Hosp, Dept Educ, Taipei 11217, Taiwan
[4] Natl Yang Ming Univ, Inst Pharmacol, Taipei 11217, Taiwan
来源
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | 2006年 / 55卷 / 02期
关键词
D O I
10.1207/s15327914nc5502_12
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocellular carcinoma (HCC) is the leading cause of cancer mortality in Asia. The aim of this study was to examine whether reactive oxygen species production is involved in quercetin-induced apoptosis in human HCC cell lines. Quercetin inhibited the growth of hepatoma cells in dose and time dependent manners. Quercetin treatment of hepatoma cells resulted in changes of cell cycle progression. The G0/G1 phase was decreased and S phase was increased in HA22T/VGH cells after treatment with quercetin. The levels of apoptotic sub-G0/G1, reactive oxygen species and annexin V were increased prior to cell death and concurrent with lipid peroxidation in two human hepatoma cells after treatment with quercetin. Quercetin also enhanced the apoptotic effect of the chemotherapeutic agent, paclitaxel, in HA22T/VGH cells. Quercetin has therapeutic potential as an anti-cancer drug. These results provide basis for further study into the potential use of quercetin in combination with paclitaxel for treatment of hepatoma.
引用
收藏
页码:201 / 209
页数:9
相关论文
共 34 条
[1]  
[Anonymous], FREE RADICALS BIOL M
[2]  
Bokemeyer C, 1996, WORLD J UROL, V14, P354
[3]   OXIDATIVE STRESS AS A MEDIATOR OF APOPTOSIS [J].
BUTTKE, TM ;
SANDSTROM, PA .
IMMUNOLOGY TODAY, 1994, 15 (01) :7-10
[4]  
CARTER WO, 1994, J LEUKOCYTE BIOL, V55, P253
[5]   Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patients [J].
Chao, Y ;
Chan, WK ;
Birkhofer, MJ ;
Hu, OYP ;
Wang, SS ;
Huang, YS ;
Liu, M ;
Whang-Peng, J ;
Chi, KH ;
Lui, WY ;
Lee, SD .
BRITISH JOURNAL OF CANCER, 1998, 78 (01) :34-39
[6]  
Chen J, 2004, PHARMAZIE, V59, P155
[7]  
Chi CW, 1997, ONCOL REP, V4, P1021
[8]   ON THE MECHANISMS OF GENOTOXICITY AND METABOLISM OF QUERCETIN [J].
GASPAR, J ;
RODRIGUES, A ;
LAIRES, A ;
SILVA, F ;
COSTA, S ;
MONTEIRO, MJ ;
MONTEIRO, C ;
RUEFF, J .
MUTAGENESIS, 1994, 9 (05) :445-449
[9]   Studies on the inhibitory effects of quercetin on the growth of HL-60 leukemia cells [J].
Kang, TB ;
Liang, NC .
BIOCHEMICAL PHARMACOLOGY, 1997, 54 (09) :1013-1018
[10]  
Lin HL, 2000, CANCER-AM CANCER SOC, V89, P983, DOI 10.1002/1097-0142(20000901)89:5<983::AID-CNCR7>3.0.CO